Key result
Increased telemedicine use during the COVID-19 pandemic was associated with a non-significant increase in 14-day follow-up rates (44.9% vs 41.7%; adjusted difference +2.0 pp, P=0.20).
Why the study?
Telemedicine use increased dramatically during the COVID-19 pandemic, but questions remained regarding how its use impacts timely follow-up and unplanned readmission after acute cardiovascular hospital encounters.
Does increased telemedicine use improve timely follow-up and prevent unplanned readmission in patients after acute cardiovascular hospital encounters?
Cohort (n=6,026)
Yes
Does increased telemedicine use improve timely follow-up and prevent unplanned readmission in patients after acute cardiovascular hospital encounters?
Answers are grounded in this paper and cite their sources.
Increased telemedicine use during the COVID-19 pandemic was associated with earlier follow-ups, particularly for heart failure, without compromising care quality as measured by readmission rates.
Telemedicine use increased dramatically during the COVID-19 pandemic; however, questions remain as to how telemedicine use impacts care. The purpose of this study was to examine the association of increased telemedicine use on rates of timely follow-up and unplanned readmission after acute cardiovascular hospital encounters. We examined hospital encounters for acute coronary syndrome, arrhythmia disorders, heart failure (HF), and valvular heart disease from a large U.S., multisite, integrated academic health system among patients with established cardiovascular care within the system. We evaluated 14-day postdischarge follow-up and 30-day all-cause unplanned readmission rates for encounters from the pandemic “steady state” period from May 24, 2020 through December 31, 2020, when telemedicine use was high and compared them to those of encounters from the week-matched period in 2019 (May 26, 2019, through December 31, 2019), adjusting for patient and encounter characteristics. The study population included 6,026 hospital encounters. In the pandemic steady-state period, 40% of follow-ups after these encounters were conducted via telemedicine vs 0% during the week-matched period in 2019. Overall, 14-day follow-up rates increased from 41.7% to 44.9% (adjusted difference: +2.0 percentage points [pp], 95% CI: −1.1 to +5.1 pp, P = 0.20). HF encounters experienced the largest improvement from 50.1% to 55.5% (adjusted difference: +6.5 pp, 95% CI: +0.5 to +12.4 pp, P = 0.03). Overall 30-day all-cause unplanned readmission rates fell slightly, from 18.3% to 16.9% (adjusted difference −1.6 pp; 95% CI: −4.0 to +0.8 pp, P = 0.20). Increased telemedicine use during the COVID-19 pandemic was associated with earlier follow-ups, particularly after HF encounters. Readmission rates did not increase, suggesting that the shift to telemedicine did not compromise care quality.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2022) conducted a cohort in Acute cardiovascular hospital encounters (n=6,026). High telemedicine use during the COVID-19 pandemic vs. Week-matched period in 2019 was evaluated on 14-day postdischarge follow-up rate (adjusted difference +2.0 pp, 95% CI -1.1 to +5.1, p=0.20). Increased telemedicine use during the COVID-19 pandemic was associated with a non-significant increase in 14-day follow-up rates (44.9% vs 41.7%; adjusted difference +2.0 pp, P=0.20).
Synapse has enriched 10 related papers. Consider them for comparative context: